Resources

Selected
  • COVID-19
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)

1589 results found

2023 ∙ van Heuvel, L. Paget, J. Dückers, M. Caini, S.

The impact of influenza and pneumococcal vaccination on antibiotic use: an updated systematic review and meta-analysis

  • All age groups
  • Influenza
  • Pneumococcal disease
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Pierre, V. Draica, F. Di Fusco, M. Yang, J. Nunez-Gonzalez, S. Kamar, J. Lopez, S. Moran, M. M. Nguyen, J. Alvarez, P. Cha-Silva, A. Gavaghan, M. Yehoshua, A. Stapleton, N. Burnett, H.

The impact of vaccination and outpatient treatment on the economic burden of covid-19 in the United States omicron era: a systematic literature review

  • Americas
  • United States of America
  • All age groups
  • COVID-19
  • Economic aspects
  • Administration
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Calabrò, G. E. Pappalardo, C. D'Ambrosio, F. Vece, M. Lupi, C. Lontano, A. Di Russo, M. Ricciardi, R. de Waure, C.

The Impact of Vaccination on COVID-19 Burden of Disease in the Adult and Elderly Population: A Systematic Review of Italian Evidence

  • Europe
  • Italy
  • Adolescents
  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Not applicable
2023 ∙ Aldali, J. A. Abutheeb, A. Al-Fahd, A. Alzakari, M. Almukhalafi, O. Al-Tayar, N. Almeziny, A. Anwer, R.

The Most Common Side Effects of AstraZeneca COVID-19 Vaccine among Saudi Arabian Population: A Systematic Review

  • Eastern Mediterranean
  • Saudi Arabia
  • All age groups
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Stoian, A. Bajko, Z. Stoian, M. Cioflinc, R. A. Niculescu, R. Arb Russu, E. Botoncea, M. Bălașa, R.

The Occurrence of Acute Disseminated Encephalomyelitis in SARS-CoV-2 Infection/Vaccination: Our Experience and a Systematic Review of the Literature

  • Adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Zhao, Sihong Hu, Simeng Zhou, Xiaoyu Song, Suhang Wang, Qian Zheng, Hongqiu Zhang, Ying Hou, Zhiyuan

The Prevalence, Features, Influencing Factors, and Solutions for COVID-19 Vaccine Misinformation: Systematic Review

  • All age groups
  • COVID-19
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2023 ∙ Hamad Saied, M. van der Griend, L. van Straalen, J. W. Wulffraat, N. M. Vastert, S. Jansen, M. H. A.

The protective effect of COVID-19 vaccines on developing multisystem inflammatory syndrome in children (MIS-C): a systematic literature review and meta-analysis

  • Children
  • Adolescents
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Rimmer, M. P. Teh, J. J. MacKenzie, S. C. Al Wattar, B. H.

The risk of miscarriage following COVID-19 vaccination: A systematic review and meta-analysis

  • Pregnant women
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Low
2023 ∙ Favas, T. T. Lall, N. Joshi, D. Singh, V. K. Pathak, A. Chakravarty, K. Mishra, V. N. Chaurasia, R. N. Kumar, A.

Thrombotic and Thromboembolic Complications After Vaccination Against COVID-19: A Systematic Review

  • All age groups
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Ratajczak, P. Banach, Z. Kopciuch, D. Paczkowska, A. Zaprutko, T. Krawczyk, J. Maciuszek-Bartkowska, B. Kus, K.

Tozinameran (Pfizer, BioNTech) and Elasomeran (Moderna) Efficacy in COVID-19-A Systematic Review of Randomised Controlled Trial Studies

  • Adolescents
  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
Loading...